Approximately 2,000 Shares Of iSpecimen Inc. (ISPC) Were Bought By This Insider.

0
19
Business man trader investor analyst using mobile phone app analytics for cryptocurrency financial stock market analysis analyze graph trading data index investment growth chart on smartphone screen.

iSpecimen Inc. (NASDAQ:ISPC) finished Thursday with a subtraction of -$0.19 to close at $1.72, a downside of -9.95 percent. An average of 400,754 shares of common stock have been traded in the last five days. There was a fall of -$0.2600 in the past week, and it reached a new high 16 times over the past 12 months. The last 20 days have seen an average of 126,773 shares traded, while the 50-day average volume stands at 101,161.

ISPC stock has decreased by -17.32% in the last month. The company shares reached their 1-month lowest point of $1.5100 on 09/22/22. With the stock rallying to its 52-week high on 01/04/22, shares of the company touched a low of $1.51 and a high of $28.98 in 52 weeks. It has reached a new high 2 times so far this year and lost -75.54% or -$6.0900 in price. In spite of this, the price is down -94.07% from the 52-week high.


China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.

Sponsored


Valuation Metrics

iSpecimen Inc. (ISPC) has a trailing price-to-sales (P/S) ratio at 1.74, the price-to-book (PB) ratio at 0.67.

Financial Health

Further, the company has a long term debt to equity ratio of 0.12 and a total debt to equity ratio of 0.14 for the quarter ending June 29. Its gross profit as reported stood at $5.89 million compared to revenue of $11.13 million.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, iSpecimen Inc.’s return on assets was -29.40%.

Earnings Surprise

For the three-month period that ended June 29, iSpecimen Inc. had $2.96 million in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of -$2.61 million in the quarter, while revenues of -$2.38 million were grew 46.74%. The analyst consensus anticipated iSpecimen Inc.’s latest quarter earnings to come in at -$0.27 per share, but it turned out to be -$0.3, a -11.10% surprise. For the quarter, EBITDA amounted to -$2.31 million. Shareholders own equity worth $8.88 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at iSpecimen Inc. (ISPC) price momentum. RSI 9-day as of the close on 22 September was 36.29%, suggesting the stock is Neutral, with historical volatility in this time frame at 167.81%.

As of today, ISPC’s price is $1.7820 -13.13% or -$0.2600 from its 5-day moving average. ISPC is currently trading -26.18% lower than its 20-day SMA and -46.75% lower than its 100-day SMA. However, the stock’s current price level is -29.22% below the SMA50 and -85.94% below the SMA200.

The stochastic %K and %D were 28.89% and 25.47%, respectively, and the average true range (ATR) was 0.2308. With the 14-day stochastic at 28.77% and the average true range at 0.1996, the RSI (14) stands at 36.01%. The stock has reached -0.1856 on the 9-day MACD Oscillator while the 14-day reading was at -0.2724.

LEAVE A REPLY

Please enter your comment!
Please enter your name here